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Abstract. 
 
The RING-ﬁnger domain is a novel zinc-
binding Cys-His protein motif found in a growing num-
ber of proteins involved in signal transduction, ubiq-
uitination, gene transcription, differentiation, and
morphogenesis. We describe a novel muscle-speciﬁc 
RING-ﬁnger protein (MURF) expressed speciﬁcally in 
cardiac and skeletal muscle cells throughout pre- and 
postnatal mouse development. MURF belongs to the 
RING-B-box-coiled-coil subclass of RING-ﬁnger pro-
 
teins, characterized by an NH
 
2
 
-terminal RING-ﬁnger 
followed by a zinc-ﬁnger domain (B-box) and a leucine-
rich coiled-coil domain. Expression of MURF is re-
quired for skeletal myoblast differentiation and myo-
tube fusion. The leucine-rich coiled-coil domain of 
MURF mediates association with microtubules, 
whereas the RING-ﬁnger domain is required for micro-
tubule stabilization and an additional region is required 
for homo-oligomerization. Expression of MURF estab-
lishes a cellular microtubule network that is resistant to 
microtubule depolymerization induced by alkaloids, 
cold and calcium. These results identify MURF as a 
myogenic regulator of the microtubule network of stri-
ated muscle cells and reveal a link between microtubule 
organization and myogenesis.
Key words: microtubule • RING-ﬁnger • cytoskele-
ton • striated muscle
 
Introduction
 
The RING-finger is an unusual type of Cys-His zinc-bind-
ing motif found in a growing number of proteins with roles
in signal transduction, gene transcription, differentiation,
 
E2-dependent ubiquitination, and morphogenesis (Borden,
 
1998; Freemont, 2000; Saurin et al., 1996). A RING-B-box-
 
coiled-coil (RBCC)
 
1
 
 subclass of RING-finger proteins con-
tains an NH
 
2
 
-terminal RING-finger followed by a single or
multiple additional zinc-finger domains, termed B-boxes,
and a leucine-rich coiled-coil domain (Borden, 1998). The
tripartite organization of these domains is evolutionarily
conserved, suggesting an integrated and functional role for
this overall protein structure. RING-finger and B-box mo-
tifs have been identified based on sequence homologies
and are predicted to function as zinc-binding domains, but
 
their precise functions have not been fully elucidated. There
is evidence suggesting that the RING-finger, B-box and
coiled-coil domains mediate protein-protein interactions
(Cao et al., 1997; Bartkiewicz et al., 1999).
Several RBCC proteins have been implicated in onco-
genesis. The RBCC member PML becomes fused to the
retinoic acid receptor alpha in acute promyelocytic leuke-
mia (De The et al., 1991). Similarly, the RBCC proteins
BRCA1, Cbl, Rfp, TIF1, and MDM2 have been demon-
strated to be oncogenic when fused to other factors through
chromosomal translocation events (Saurin et al., 1996).
Other RBCC proteins have been implicated in signal trans-
duction, E2-dependent ubiquitination, organellar biogene-
sis, chromosomal dynamics, viral pathogenesis, transcrip-
tion, and developmental patterning (Saurin et al., 1996;
Freemont, 2000).
Recently, a complex congenital human disease, Opitz
G/BBB syndrome, was shown to result from mutations in
 
the RBCC protein, Midl (Quaderi et al., 1997). Opitz G/BBB
syndrome is characterized by abnormalities of midline
structures, including hypertelorism, clefts of lip and palate,
larygotracheoesophageal defects, hypospadias, imperfo-
rate anus, and developmental delay. The Midl gene prod-
uct is widely expressed during development and interacts
with microtubules throughout the cell cycle (Cainarca et
al., 1999). Overexpression of Mid1 leads to a stable pop-
ulation of microtubules resistant to depolymerization
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(Schweiger et al., 1999). Interestingly, mutations of Midl
that are linked to Opitz G/BBB syndrome severely dimin-
ish the ability of Midl to interact with microtubules, sug-
gesting that Midl-microtubule interaction and/or microtu-
bule dynamics are involved in the processes required for
normal development of the midline structures affected in
Opitz G/BBB syndrome.
We describe a novel RBCC protein, MURF (muscle-
specific RING finger) that shows significant homology to
Midline proteins in the RING-finger and B-box regions,
but is structurally distinct. MURF expression is restricted
to cardiac and skeletal muscle throughout pre- and postna-
tal development. Like Mid1, MURF binds and stabilizes
microtubules against depolymerizing agents. Perturbation
of MURF expression in C2 muscle cells inhibits myogenic
differentiation. These properties of MURF suggest its in-
volvement in microtubular stabilization in striated muscle
cells, which previous studies have shown to be important
for alignment of skeletal myoblasts during fusion, myo-
fibrillar assembly, and contractile abnormalities in cardiac
hypertrophy. The finding that MURF expression is re-
quired for execution of the muscle differentiation program
also reveals a potential link between microtubule function
and myogenesis.
 
Materials and Methods
 
Yeast Two-Hybrid Screen
 
Yeast two-hybrid screens of an adult mouse heart cDNA library were per-
formed using full-length serum response factor (SRF) fused to the GAL4
DNA binding domain, as described previously (Spencer et al., 1999). Plas-
mids were isolated and transformed into electrocompetent XL1-Blue 
 
E.
coli
 
. Plasmids were prepared by alkaline lysis extraction and sequenced.
Sequence analysis and comparison was performed using the NCBI web
site Blast program.
We identified a cDNA encoding a novel muscle-specific RING-finger
protein that interacted with GAL4-SRF. However, subsequent attempts
to demonstrate interaction between SRF and MURF, or colocalization of
the proteins in mammalian cells, were unsuccessful. Thus, we do not be-
lieve this interaction is biologically significant, but it may reflect an ability
of SRF to interact with other RING-finger proteins, as several such pro-
teins have been shown to regulate transcription (Hsieh et al., 1999). Nev-
ertheless, because of its interesting structure and expression pattern (see
Fig. 2), we continued to characterize this novel factor.
 
Mammalian Expression Plasmid Construction
 
Full-length MURF expression plasmids and COOH-terminal deletion mu-
tants were constructed by PCR using Expand High Fidelity polymerase
(Roche) and cloned in-frame into vector pcDNA3.1 myc/HIS (Invitrogen)
or pECE-Flag. Native MURF was cloned into vector pcDNA1.1. NH
 
2
 
-ter-
minal deletion mutants were constructed by PCR, generating an initiator
methionine at desired positions and cloned into the SacII and HindIII sites
of full-length MURF in vector pcDNA3.1 myc/HIS. The SacII site is imme-
diately downstream of the Kozak translation initiation sequence contained
in the MURF cDNA. The Flag-tagged versions of MURF were subcloned
into pcDNA3.1 for use in in vitro analyses.
 
Radioactive In Situ Hybridization
 
RNA probes corresponding to the sense and antisense strands of the
MURF cDNA were prepared using T7 RNA polymerase (Roche). In situ
hybridization was performed as previously described (Benjamin et al.,
1997).
 
Cell Culture, Transfection, Alkaloid Treatment,
and Immunofluorescence
 
Cos-l, HeLa, 10T1/2, 293, 3T3 and 293T cells were maintained in DME
 
supplemented with 10% heat-inactivated FBS. C2 cells were maintained
in DME containing 20% heat-inactivated FBS. Cells were transfected
with 1 
 
m
 
g of various MURF expression plasmids using Fugene6 reagent as
recommended by the manufacturer (Roche). 293T cells were transfected
using the calcium phosphate coprecipitation technique (Spencer and
Misra, 1996). Cells were treated for 2 h with 2 
 
m
 
M nocodazole (Sigma-
Aldrich) or 2 
 
m
 
M cytochalasin D (Sigma-Aldrich) as indicated.
For immunofluorescence, cells were either extracted with 1% Triton
X-100 in PBS for 1 min, washed twice in PBS, and fixed for 15 min in 3.7%
formalin plus 0.25% glutaraldehyde (Sigma-Aldrich) in PBS or immedi-
ately washed with PBS and then fixed in 3.7% formalin solution. Cells
were then washed three times in PBS and blocked in PBS containing 3%
BSA and 0.1% NP40 for 30 min. All antibodies were incubated in fresh
block solution for 60 min at ambient temperature. Myc-tagged versions of
MURF were detected using antibody 9El0 (Santa Cruz) at a dilution of
1:250. Flag-tagged versions of MURF were detected using the M2 Flag an-
tibody at a dilution of 1:500 (Kodak). Microtubules were detected using
alpha-tubulin antibody at a dilution of 1:2,000 (Sigma-Aldrich). Intermedi-
ate filaments were visualized using vimentin antibody at a dilution of 1:500
(Sigma-Aldrich). Actin was visualized using rhodamine-conjugated phal-
loidin (Sigma). Myosin heavy chain was visualized using anti-myosin
heavy chain antibody MY32 (Sigma-Aldrich) at a dilution of 1:250. Sec-
ondary antibodies were purchased from Vector labs and used at a dilution
of 1:400 in fresh block solution. For cryo-sections of mouse quadriceps,
MURF antibody UT82 was used at a dilution of 1:200 and alpha-tubulin
antibody was used at a dilution of 1:500.
 
In Vitro Transcription/Translation
and Immunoprecipitation
 
In vitro transcription/translation was performed as directed by the manu-
facturer (Promega). Plasmids used were native MURF in pcDNA1.1,
COOH-terminally myc-tagged full-length MURF and various myc-tagged
deletions of MURF. Immunoprecipitations were performed using 
 
35
 
S-
methionine–labeled in vitro translation products. In brief, 
 
35
 
S-methio-
nine–labeled products were incubated with agitation in 1 ml immunopre-
cipitation buffer (PBS, 0.5% Triton X-100, 0.25 mM zinc sulphate) at
4
 
8
 
C for 2 h. 2.5 
 
m
 
l myc-antibody 9E10 was added and incubated an addi-
tional 60 min. 20 
 
m
 
l protein A/G-plus beads (Santa Cruz) were added and
incubated 60 min. Reactions were centrifuged at 2,500 rpm for 5 min at
4
 
8
 
C. Pellets were washed with rocking for 5 min in 1 ml immunoprecipita-
tion buffer. Washing was repeated 4 times before resuspension of the
pellet in 20 
 
m
 
l SDS-sample buffer. Approximately 10 
 
m
 
l was used in SDS-
PAGE analysis. Gels were dried under vacuum and results were visual-
ized by autoradiography.
 
Northern Blot Analysis, RNA Isolation and RT-PCR
 
Northern blot analysis was performed using a multiple tissue Northern
blot from Clontech and 
 
32
 
P-labeled probe made from the MURF full-
length cDNA. Hybridization was performed for 1 h using rapid-hybe
buffer (Amersham). C2 cells were induced to differentiate by the addition
of DME supplemented with 2% horse serum. Cells were incubated for
various lengths of time and total RNA isolated by TriZol extraction
(GibCo). RT-PCR was performed as described in Rawls et al. (1998).
Approximately 7 
 
m
 
g total RNA was used in the slot blot analysis and hy-
bridization conditions were as described above.
 
UT 82 Antibody Production
 
An NcoI-HindIII fragment spanning the coding region for amino acids
271–366 of MURF was fused in-frame into vector pGEX2T-polyG. BL21-
DE3 cells containing the GST-fusion expression plasmid were grown to an
optical density of 0.5 and induced with 1 mM IPTG for 3 h at 30
 
8
 
C. Cells
were pelleted and washed in ice-cold PBS. Lysis was induced by sonica-
tion and protein was purified by GST-affinity chromatography using
standard techniques. Rabbit immunization was conducted at Cocalico Bi-
ological.
 
Western Blot
 
Whole cell extracts from mouse tissues and C2 cells were prepared as de-
scribed previously (Spencer et al., 1999). Approximately 25 
 
m
 
g total pro-
tein was used in the analysis. MURF UT82 was used at a dilution of 1:4,000,
anti–Glu-tubulin was used at a dilution of 1:2,000, anti-tubulin was used
at a dilution of 1:10,000, and anti-myogenin (Santa Cruz) was used at a 
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dilution of 1:500. Mouse and rabbit HRP-conjugated secondary antibod-
ies were used at a dilution of 1:5,000. Chemiluminescence was detected us-
ing Luminol Reagent (Santa Cruz).
 
Microtubule Sedimentation Assays
 
For endogenous MURF-microtubule cosedimentation experiments,
2-mo-old female mice were killed by standard protocols; hearts and
quadriceps (100 mg each tissue) were removed, and placed in ice-cold
PBS containing protease inhibitors (Roche) for 20 min. Tissue was finely
minced and placed in 1 ml PCM buffer (0.1 M Pipes, pH 6.9, 2.5 mM
CaCl
 
2
 
, 1 mM MgSO
 
4
 
, pH 6.9) plus protease inhibitors. This was promptly
homogenized in a ground glass Dounce homogenizer with 25–30 strokes
on ice. Nuclei and debris were removed by low speed centrifugation (3,000
rpm) for 5 min at 4
 
8
 
C. The supernatant was centrifuged at 100,000 
 
g
 
 for 30
min at 4
 
8
 
C to remove cytoplasmic contaminants. The resulting superna-
tant was used in the microtubule sedimentation analysis. The supernatant
was supplemented with 2 mM GTP and 5 mM EGTA and incubated at
37
 
8
 
C for 20 min. This was layered onto a 25% sucrose cushion in PEM
buffer (0.1 M Pipes, 1 mM EGTA, 1 mM MgSO
 
4
 
) plus 1 mM GTP and cen-
trifuged at 20,000 
 
g
 
 for 30 min at room temperature. The supernatant was
removed and acetone precipitated. The pellet was resuspended in PEM
buffer minus GTP and supplemented to 2 mM CaCl
 
2
 
. This was placed on
ice for 30 min. The second polymerization was induced by adding EGTA
and GTP to 5 mM and 1 mM, respectively, and incubation at 37
 
8
 
C. Poly-
merization-depolymerization was repeated three times to avoid cytoplas-
mic contamination. The final polymerization was induced as described
above and supplemented with 20 
 
m
 
M taxol (Sigma-Aldrich). The resulting
microtubule pellet was resuspended in 50 
 
m
 
l  PEM. Approximately 25 
 
m
 
g
protein was used for Western analysis. For microtubule sedimentation as-
says using transfected cells, cells were harvested and treated as described
in (Kaufmann et al., 1999).
 
Adenoviral Transduction
 
MURF cDNA was cloned in the antisense orientation into vector pAC-
CMV.pLpA as a KpnI-XbaI fragment creating anti-MURF. The ade-
noviral expression plasmid encoding GFP (Ad-GFP) was constructed by
cloning the GFP cDNA into vector pACCMV.pLpA. Replication-defi-
cient adenovirus was created by cotransfecting plasmid JM17 and anti-
MURF into 293T cells. C2C12 cell infection was performed for 24 h in
growth medium, followed by 5 washes in PBS and transfer to differentia-
tion medium. Infection efficiency was monitored by fluorescence using
Ad-GFP. Typically, 75–85% of the cells expressed GFP 48 h after infec-
tion.
 
Retroviral Transduction
 
The myogenin cDNA was cloned into vector MSCV/puro as an EcoRI
fragment for virus production. Helper-virus free replication-defective ret-
roviral supernatants were obtained by transient transfection of 293T cells
with an ecotropic packaging construct. C2 cells were transduced in the
presence of 8 
 
m
 
g polybrene for 3–4 h, then the medium was changed to
fresh medium and cells allowed to recover overnight. Cells were selected
for 3–6 d in the presence of 2 
 
m
 
g/ml puromycin. Expression of myogenin
was confirmed by Western blot analysis.
 
Results
 
MURF Domain Structure and Similarity to Midline 1 
and 2
 
The MURF cDNA encodes a 366–amino acid protein with
a predicted molecular mass of 41 kD and pI of 4.82 (Fig. 1
A, data are available from GenBank/EMBL/DDBJ under
accession number AF294790; see Materials and Methods
for method of identification of MURF). MURF contains
several domains that identify it as a RBCC-type of RING-
finger protein. A RING-finger of the C
 
3
 
HC
 
4
 
 type is lo-
cated near the NH
 
2
 
 terminus (amino acids 26–81), fol-
lowed by another type of zinc-finger termed a B-box
(amino acids 126–158; Fig. 1 B). In all other RBCC pro-
teins, the spacing between the RING-finger and B-box is
also 
 
z
 
40 amino acids (Borden, 1998; Saurin et al., 1996). A
predicted leucine-rich coiled-coil domain (amino acids
212–253) and an acidic region (amino acids 335–366) are
located in the COOH-terminal portion of the protein.
Database searches with the amino acid sequence of
MURF revealed highest homology to the Opitz-G/BBB
syndrome protein Mid1 and the related factor Mid2 (Fig. l,
C and D) with greatest homology in the RING-finger and
B-box domains. Interestingly, MURF does not contain a
region corresponding to the first B-box of Midl and Mid2
nor the butyrophilin-like domain at the COOH termini of
Mid2 and Mid2, suggesting functional differences between
the proteins.
 
MURF Expression Is Restricted to Striated Muscle
 
The expression pattern of MURF was examined during
mouse embryogenesis by in situ hybridization. At E8.5,
MURF expression was observed only in the developing
cardiac region and at E10.5 expression was restricted ex-
clusively to the heart and the myotome of the somites
which gives rise to skeletal muscle. This muscle-specific
expression continued throughout prenatal development,
with expression observed in the heart and skeletal muscle
of the intercostals, diaphragm, limbs, face, and head (see
Fig. 2 A).
In adult mice, Northern analysis showed a single MURF
transcript of 
 
z
 
1.5 kb in cardiac and skeletal muscle (Fig. 2
B). Extended exposures (
 
.
 
6 d) revealed a very low level
of expression in the lung and brain (not shown). Consis-
tent with the restricted expression of MURF mRNA,
Western blot analysis of protein from mouse heart, quadri-
ceps, spleen and lung, using anti-MURF antibody, de-
tected MURF protein only in heart and skeletal muscle
(Fig. 2 C). The size of the protein, 41 kD, was in agree-
ment with the size predicted from the open reading frame.
We also examined expression of MURF during differen-
tiation of the C2 skeletal muscle cell line. As shown in Fig.
2 D, MURF transcripts, measured by semi-quantitative
RT-PCR, were expressed in a pattern that mirrored that of
MyoD. Like MyoD, MURF expression was detected in
proliferating myoblasts before expression of myogenin
and was upregulated during myoblast differentiation.
MURF expression was also observed well before the ex-
pression of muscle differentiation genes such as skeletal
 
a
 
-actin, suggesting an early role for MURF in myogenesis.
This is consistent with expression observed in the myo-
tome and with functional studies described below.
 
MURF Is a Necessary Component of Myogenic 
Differentiation and Myotube Formation
 
Given the early expression of MURF in the developing
myotome and increased expression of MURF during
skeletal muscle differentiation in vitro, we investigated
whether MURF might play a regulatory role during differ-
entiation. To investigate this possibility, MURF expression
was ablated by an adenovirus-delivered MURF antisense
expression vector in C2 cells. Myoblasts were infected for
24 h and then switched to differentiation media for various
lengths of time. As seen in Fig. 3 A, efficient expression of
the MURF antisense transcript was detected 1 day after 
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adenovirus infection and was maintained for 2–4 d after
infection, decreasing in expression with time. Western blot
analysis showed that MURF protein expression was effi-
ciently inhibited by antisense treatment for up to 3 d post-
infection.
To determine if the absence of MURF protein had an
effect on myotube formation, immunofluorescence was
performed to detect the late muscle marker myosin heavy
chain (MHC). The ablation of MURF expression severely
diminished MHC expression (Fig. 3, compare B with C)
and concomitant myotube formation. The stage at which
differentiation was inhibited was also assessed by measur-
ing muscle transcripts by RT-PCR. As seen in Fig. 3 D,
compared with untreated or AdGFP-infected cells, MURF
ablation inhibited the expression of the early myogenic
regulatory factors, MyoD and myogenin. These data sug-
gest that MURF is required for the initiation of myogene-
sis in vitro.
We next created stable C2 cells constitutively expressing
myogenin to investigate whether constitutive expression
of myogenin, an essential myogenic regulator, could by-
pass the requirement of MURF for initiation of myogene-
sis (see Fig. 3, E and F). Ablation of MURF expression in
this background resulted in expression of MHC without
myotube formation. Interestingly, while MHC was ex-
pressed, many cells showed collapsed MHC localization
compared with uninfected myogenin overexpressing cells,
suggesting that cytoskeletal integrity was compromised.
These data, taken together, demonstrate that MURF has a
role in myogenesis at two separate steps, initiation and
myotube formation.
 
Endogenous MURF Cosediments with and Colocalizes 
with Microtubules from Striated Muscle
 
Given the amino acid homology between Mid1 and
MURF and the ability of Midl to interact with microtu-
bules (Cainarca et al., 1999; Schweiger et al., 1999), we in-
vestigated whether MURF was also a microtubule-binding
protein. To determine if MURF associated with microtu-
bules, microtubule sedimentation assays were performed
using soluble extracts prepared from mouse skeletal mus-
cle and heart. As seen in Fig. 4 A, MURF was contained in
the microtubule pellet from these muscle extracts and was
absent from the supernatant, demonstrating a physical as-
sociation between MURF and microtubules in vivo. No
contaminating actin filaments or intermediate filaments
were detected in the microtubule pellets under these ex-
perimental conditions (not shown). Interestingly, the ma-
jority of MURF was contained in the initial high speed
Figure 1. Amino acid sequence of MURF and structural similarity to Midline proteins. (A) Deduced amino acid sequence of MURF.
The RING-finger domain is boxed, the B-box domain is shaded, and the coiled-coil domain is underlined. (B) Schematic diagrams of
MURF and Midline proteins. (C and D) Amino acid homologies between the RING-finger and B-box domains, respectively, of MURF
and Midline proteins. 
Spencer et al. 
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pellet before microtubule polymerization, suggesting its
association with cold-stable microtubules that sediment in
the initial high speed centrifugation or with structures in
addition to microtubules (see below).
In agreement with the apparent association of MURF
with microtubules in skeletal muscle extracts (Fig. 4 A),
immunostaining of cryosections of mouse quadriceps re-
vealed a portion of MURF colocalizes with microtubules
in vivo (Fig. 4, B–D). Consistent with MURF being
present in the initial high speed pellet before microtubule
polymerization, MURF was also associated with Z-lines in
skeletal muscle. This raises the interesting possibility that
MURF links microtubules to the Z-line in striated muscle
by interacting with known or novel Z-line components
(manuscript in preparation).
 
The Leucine-rich Coiled-Coil Domain Is Necessary and 
Sufficient for Interaction with Microtubules
 
Given that endogenous MURF cosedimented with micro-
tubules from striated muscle, we next mapped the domain
of MURF required for association with microtubules.
293T fibroblasts were transfected with plasmids expressing
wild-type and deletion mutants of Myc-tagged MURF, si-
multaneously treated with nocodazole for 24 h to prevent
microtubule association, and soluble extracts prepared. As
seen in Fig. 5 C, full-length MURF cosedimented with mi-
crotubules in transfected cells. All MURF deletion mu-
tants containing the leucine-rich coiled-coil domain also
cosedimented with microtubules. Interestingly, mutant
N212, which contains only the leucine-rich coiled-coil do-
main, was also partially contained in the supernatant after
microtubule pelleting (Fig. 5 C, lane 5). Since mutant N167
was localized exclusively to the microtubule pellet, this
suggests that although the leucine-rich coiled-coil domain
is sufficient for association with microtubules, this domain
also requires amino acids 168–211 for optimal interaction.
Mutant C154, lacking the COOH-terminal leucine-rich
coiled-coil domain, failed to pellet with microtubules and
was contained exclusively in the supernatant. These data
further demonstrate that MURF is capable of cosediment-
ing with microtubules, the leucine-rich coiled-coil domain
is both necessary and sufficient for microtubule associa-
tion, and maximal binding requires amino acids 168–211
under experimental conditions used.
 
The RING-Finger Domain Is Required for Continuous 
Interaction along the Entire Length of the Microtubule
 
To determine if deletions of MURF used in Fig. 5 changed
the subcellular distribution of MURF, HeLa cells were
transfected and immunofluorescence performed. As seen
in Fig. 6 A, MURF was incorporated into an undulating
reticular network in the cytoplasm, reminiscent of the sub-
cellular distribution of Mid1 and Mid2 (Buchner et al.,
1999; Cainarca et al., 1999; Schweiger et al., 1999). This
network was extremely stable, remaining intact even after
extraction with 1% Triton X-100 (data not shown). The re-
sistance to extraction in high detergent concentrations
suggested that MURF associated with a cytoskeletal com-
ponent.
To determine if MURF colocalized with microtubules in
Figure 2. Muscle-specific ex-
pression of MURF RNA and
protein. (A) Detection of
MURF transcripts by in situ
hybridization to mouse em-
bryo sections. A transverse
section through an E8.5 em-
bryo shows expression exclu-
sively in the cardiac forming
region. A transverse section
through an E10.5 embryo
shows expression in the heart
and myotomes. A sagittal
section through an E16.5
embryo shows expression
throughout skeletal muscle
and heart. a, atria; m, myo-
tome; hf, head folds; nt,
neural tube; v, ventricle.
(B) Northern analysis of
poly(A)1 mRNA from adult
mouse tissues. A 1.5-kb
MURF transcript is detected
only in heart and skeletal
muscle. (C) Western blot
analysis of MURF protein in
extracts from adult mouse
tissues. The 41-kD MURF
protein is detected only in heart and skeletal muscle. Blotting with anti-tubulin antibody confirmed equal quantities of protein in each
lane. (D) RT-PCR analysis of RNA from C2 cells in growth medium (GM) or differentiation medium (DM) for 1 or 3 d, as indicated.
MURF transcripts are detected at low levels in undifferentiated myoblasts in GM and are upregulated during differentiation. L7 is ex-
pressed constitutively and is a control for RNA loading. 
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Figure 3.
 
MURF expression is required for the initiation of myo-
genesis and myotube formation. (A) C2 myoblasts were infected
at a multiplicity of infection (MOI) of 200 with an adenovirus ex-
pressing antisense RNA to MURF (Anti-MURF) for 24 h in
growth medium and switched to differentiation medium. RNA
and protein extracts were isolated at 0, 1, or 3 d of differentiation,
and RNA slot blot and Western blot analyses were performed to
detect MURF RNA and protein expression. MURF antisense
transcripts are efficiently expressed immediately after infection
and continue up to 3 d after infection. MURF protein expression
is severely reduced in the presence of Anti-MURF for up to 3 d
after infection. C2 myoblasts were infected with Ad-GFP as a
control (B) or Anti-MURF (C) and induced to differentiate for
3 d. Cells were fixed and immunofluorescence performed using
anti-myosin heavy chain antibodies to visualize myotube mor-
phology. Inhibition of MURF expression blocks the accumula-
tion of myosin heavy chain and myotube formation. (D) RT-PCR
analysis of myogenic markers at day 3 of differentiation of mock-
infected, Ad-GFP–infected, or Anti-MURF–infected C2 cells.
Mock-infected and Ad-GFP–infected C2 cells express the myo-
genic markers MyoD, myogenin, desmin, and skeletal 
 
a
 
-actin.
Anti-MURF–expressing C2 cells fail to express these myogenic
markers. L7 transcripts are expressed constitutively and serve as
a control for RNA input. C2 cells engineered to overexpress
myogenin were infected with Ad-GFP (E) or Anti-MURF (F)
and immunofluorescence performed to detect skeletal myosin
 
heavy chain expression as in B and C. C2 cells overexpressing
myogenin differentiate normally and express myosin heavy
chain. Blocking MURF expression in myogenin overexpressing
cells results in a decrease in myotube formation but expression of
MHC was unaffected.
Figure 4. Association of MURF with microtubules demonstrated
by microtubule sedimentation assay and immunolocalization of
MURF in skeletal muscle. (A) Microtubule cosedimentation of
endogenous MURF protein from striated muscle. Microtubules
from soluble extracts from striated muscle were induced to poly-
merize as described in Materials and Methods. MURF was con-
tained in the microtubule pellet from striated muscle. Ctrl lane
was loaded with heart extract mixed with purified tubulin before
polymerization. (B–D) Localization of MURF to microtubules in
skeletal muscle by immunofluorescence with anti-MURF anti-
body UT82 raised against the COOH-terminal 95 amino acids of
MURF, as described in Materials and Methods. (B) MURF
staining alone. (C) Microtubules staining alone. (D) Overlay of B
and C. The white arrows indicate regions of direct overlap of
MURF staining and microtubule staining. MURF is localized to
microtubules as well as Z-lines in skeletal muscle. 
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this assay, coimmunofluorescence was performed using
antibodies specific to tubulin. Microtubules showed strong
colocalization with MURF (Fig. 6, B and C), in agreement
with the results of in vivo microtubule cosedimentation, in
vitro microtubule binding assays, and in vivo coimmuno-
fluorescence (see Figs. 4 and 5). There was no overlap of
MURF localization with actin and only partial overlap
with intermediate filaments at regions where microtubules
and intermediate filaments were in close proximity (data
not shown). Similar localization of endogenous MURF
to microtubules was observed in skeletal muscle (Fig. 4,
B–D).
As shown in Fig. 6, D and E, deletion of the 16 NH
 
2
 
-ter-
minal residues of MURF (mutant N16) did not disrupt
colocalization with microtubules. However, the tubular
structures formed with mutant N16 MURF were discon-
tinuous. The significance of this redistribution is unclear.
This discontinuous pattern is also reminiscent of the mi-
tochondrial distribution along microtubules. Staining of
MURF-transfected cells with Mito-tracker dyes revealed
partial overlap of MURF and mitochondria. However,
subsequent purification of mitochondria from mouse
hearts revealed no MURF protein associated with the mi-
tochondrial fraction (data not shown). Deletion of amino
acids 1–81 (mutant N81), removing the RING-finger do-
main, also did not abolish microtubule association, but
prevented continuous association along the length of the
microtubule (Fig. 6, D and F). Truncation of MURF to
amino acid 167 (mutant N167), deleting the B-box do-
main, resulted in similar microtubule association without
continuous binding as seen with full-length MURF protein
(Fig. 6 D, and data not shown), indicating that the B-box is
not involved in microtubule binding. Deletion of amino
acids 1–212 (mutant N212), leaving only the leucine-rich
coiled-coil domain and acidic COOH terminus, again pre-
vented continuous binding along microtubules without af-
Figure 5. Mapping of domains of MURF required for association with tubulin by cosedimentation. (A) Schematic representation of the
experimental protocol used in the in vitro microtubule cosedimentation assay. 293T cells treated with nocodazole were transfected with
various myc-tagged versions of MURF and soluble extracts prepared. Purified tubulin was added and microtubules were polymerized in
the presence of GTP and EGTA. Polymerized microtubules were pelleted and the resulting supernatant was acetone-precipitated. The
microtubule pellet was subjected to depolymerization by calcium and cold treatment. Three cycles of polymerization-depolymerization
were repeated before Western analysis. (B) Representation of MURF deletions used in the analysis and summary of domains required
for microtubule binding. The leucine-rich coiled coil domain is necessary and sufficient for microtubule interaction (lane 5) but requires
amino acids 168–211 for optimal binding (compare lanes 4 and 5). (C) Western blot analysis of MURF cosedimentation with microtu-
bules. MURF mutants containing the leucine-rich coiled-coil domain cosediment with microtubules. An equivalent amount of MURF
mutant N212 is contained in the supernatant and microtubule pellet (lane 5), indicating that amino acids 168–211 are required for opti-
mal microtubule association. Mutant C154, lacking the leucine-rich coiled-coil domain, fails to cosediment with microtubules. The blot
was reprobed for a-tubulin to assess the extent of microtubule polymerization. Densitometric analysis revealed .90% of the tubulin in-
put was contained in the microtubule pellet. 
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fecting microtubule association (Fig. 6 D and see Fig. 4).
Instead, as observed with mutants N81 and N167, particu-
late structures were formed that colocalized with microtu-
bules. Detergent extraction of transfected cells before fix-
ation revealed that significant proportions of mutants N81,
N167, and N212 were associated with microtubules and
not free aggregates of protein (not shown). Deletion of the
COOH-terminal acidic region (mutant C31) did not affect
the association of MURF with microtubules nor continu-
ous binding along microtubules (Fig. 6 D, and not shown).
Truncation of the acidic and coiled-coil region of MURF
(mutant C154) produced diffuse cytoplasmic staining that
did not colocalize with microtubules (Fig. 6, D and G).
Mutant C154 was readily detergent extractable from the
cytoplasm before fixation, indicating it is not bound to mi-
crotubules nor any other cytoskeletal component (not
Figure 6. Mapping of do-
mains of MURF required for
microtubule localization by
immunofluorescence. (A–C)
HeLa cells were transfected
with myc-tagged MURF and
immunofluorescence per-
formed. MURF (green) di-
rectly colocalizes with micro-
tubules (red) as seen in C.
Yellow color in C is the result
of direct overlap of MURF
and microtubule localiza-
tion. (D) Summary of dele-
tion mapping of microtubule
binding domain of MURF.
All mutants containing the
leucine-rich coiled-coil do-
main interact with microtu-
bules, whereas mutant C154
lacking the coiled-coil do-
main does not. The RING-
finger is required for con-
tinuous binding along
microtubules. (E) Deletion
of the NH2-terminal 16 amino
acids (N16) does not inhibit
microtubule interaction but
alters the filaments to a dis-
continuous assembly. The
two larger white boxes are
magnifications of the area of
the cell outlined by the
smaller white box. The left
panel shows microtubules
only and the right panel
shows MURF and microtu-
bule overlay. Note the direct
overlap of microtubules and
MURF protein designated by
arrows. (F) Deletion of the
RING-finger domain (N81)
does not inhibit microtubule
binding, but prevents contin-
uous binding along microtu-
bules. The two larger white
boxes are magnifications of
the area of the cell outlined
by the smaller white box. The
left panel shows microtubules
only, and the right panel
shows MURF and microtu-
bule overlay. The arrows designate direct overlap of mutant N81 and microtubules. (G) Deletion of the leucine-rich coiled-coil (C154)
prevents microtubule association. Mutant C154 is diffusely localized throughout the cytoplasm. The two larger white boxes in the cor-
ners of the panel are magnifications of the area of the cell outlined by the smaller white box. The left panel shows microtubules only,
and the right panel shows C154 and microtubules. Note MURF mutant C154 localization is diffuse and lacks organization. Identical re-
sults were obtained in multiple cell types. 
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shown). Deletion analyses were performed in Cos, 10T1/2,
and 3T3 cells with identical results. Taken together, these
data confirm that the leucine-rich coiled-coil region of
MURF is necessary and sufficient for colocalization with
microtubules, whereas the RING-finger is required for
continuous binding along microtubules. These data also
demonstrate that in cells MURF associates with microtu-
bules with the greatest affinity if the RING-finger domain
is intact.
 
MURF Homo-oligomerization Is Mediated by Amino 
Acids 168–211 and the Leucine-rich
Coiled-Coil Domain
 
Coiled-coil domains often mediate protein-protein inter-
actions (Li et al., 1994; Cao et al., 1997; Bartkiewicz et al.,
1999). To determine if the leucine-rich coiled-coil domain
might mediate homo-oligomerization of MURF, we per-
formed coimmunoprecipitation experiments using Myc-
tagged MURF and native MURF translated in vitro. As
summarized in Fig. 7, A and B, MURF was able to self-
associate. Deletion of the RING-finger, and B-box (mu-
tants N81, N122, and N167) did not affect homo-oligo-
merization, whereas deletion of amino acids 168–211
abolished homo-oligomerization (mutant N212). Interest-
ingly, MURF lacking the leucine-rich coiled-coil domain
but retaining amino acids 168–211 failed to homo-oligo-
merize. These data demonstrate that amino acids 168–211
and the leucine-rich coiled-coil domain comprise the
homo-oligomerization domain of MURF. Of note, MURF
containing the RING-finger domain was able to be pel-
leted at high speed in the absence of precipitation while
Figure 7. Mapping domains of MURF re-
quired for homo-oligomerization. (A) Vari-
ous COOH-terminal myc-tagged MURF
variants and full-length native MURF were in
vitro–translated in the presence of 35S-methi-
onine and immunoprecipitation performed as
described in Materials and Methods. Full-
length native MURF is immunoprecipitated
with full-length MURF-myc. Deletion of the
RING-finger and B-box do not affect homo-
oligomerization. Amino acids 168–211 and
the leucine-rich coiled-coil domain mediate
homo-oligomerization of MURF (compare
N167, N212, and C154). Deletions of MURF
unable to homo-oligomerize are marked with
an asterisk. HeLa cells were transfected with
Flag-tagged full-length MURF alone (C) or
in combination with myc-tagged MURF (D
and E) and immunofluorescence performed.
Flag-tagged MURF forms aggregates in the
cytoplasm of the cell. In the presence of myc-
tagged MURF, the Flag-tagged MURF and
myc-tagged MURF are colocalized in fila-
mentous structures in the cell. 
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mutant N81, lacking the RING-finger, was not (not shown),
suggesting that although the RING-domain is not required
for homo-oligomerization, it may mediate the formation
of large MURF-containing aggregates. This is consistent
with the lack of continuous microtubule binding by mu-
tants lacking the RING-finger domain.
While constructing epitope-tagged versions of MURF,
we observed that the Flag-tag placed at the NH
 
2 
 
terminus
of MURF completely inhibited interaction with microtu-
bules, resulting in formation of protein aggregates (see
Fig. 7 C). Therefore, to determine if MURF was capable
of associating with microtubules as a homo-oligomer, the
NH
 
2
 
-terminal Flag-tagged MURF and the COOH-termi-
nal myc-tagged MURF were transfected separately or in
combination into HeLa cells and immunofluorescence was
performed. As seen in Fig. 7 C, the Flag-tagged MURF
did not significantly colocalize with microtubules, instead
forming large aggregates. In contrast, coexpression of
Flag-MURF and the COOH-terminal myc-tagged version
resulted in colocalization of both tagged version along the
same filamentous structures (Fig. 7, C and D). This dem-
onstrates that MURF is capable of associating with micro-
tubules as a homo-oligomer. These data, taken together
with Fig. 5, demonstrate that MURF associates with mi-
crotubules most efficiently as a homo-oligomer.
 
MURF Stabilizes Microtubules
 
Recently, Midl was shown to associate with and stabilize
microtubules (Cainarca et al., 1999; Schweiger et al.,
1999). Given the homology of MURF with Midl and the
ability of endogenous MURF to colocalize and sediment
with microtubules, we determined if MURF was able to
 
stabilize microtubules in cultured cells. Cos cells were
transfected with MURF expression plasmid, cultured for
2 h in the presence of 2 
 
m
 
M nocodazole, detergent ex-
tracted, and MURF expression was examined by immu-
nofluorescence. As shown in Fig. 8, A–C, MURF prevented
depolymerization of microtubules in the presence of no-
codazole. In untransfected cells lacking MURF, microtu-
bules were completely depolymerized as indicated by the
absence of microtubule staining. Similar results were ob-
tained using cold incubation or calcium treatment of de-
tergent-extracted cells to destabilize microtubules (not
shown). Of note, the microtubules bound by MURF ap-
pear much thicker relative to non-MURF bound microtu-
bules, suggesting MURF bundles microtubules. This was
only observed in Cos cells and not HeLa, 10T1/2, nor
NIH3T3 fibroblasts. Therefore, we believe the bundling
observed is cell line-dependent and not a general property
of MURF.
To identify the domain of MURF required for microtu-
bule stabilization, the previously described deletion mu-
tants of MURF were examined for their ability to protect
microtubules from depolymerization in transfected Cos
cells. MURF mutants lacking the NH
 
2
 
-terminal 16 amino
acids or the COOH-terminal 31 amino acids (mutants N16
and C31) were able to protect microtubules from destabili-
zation to a degree comparable to that of full-length MURF
(Fig. 8 D). Interestingly, deletion mutants of MURF lack-
ing the RING-finger (N81) did not stabilize microtubules.
This demonstrates that the microtubule stabilizing effects
of MURF are dependent on the ability to continuously
bind along microtubules. As expected, deletion of the leu-
cine-rich coiled-coil domain (C154), required for microtu-
bule association, did not stabilize microtubules.
Figure 8. Mapping domains of
MURF required for microtubule
stabilization. (A–C) Expression
of MURF stabilizes microtu-
bules. Cos cells were transfected
with a MURF expression plas-
mid, treated with 2 mM nocoda-
zole for 2 h and immunostained
for MURF and tubulin. As seen
in C, MURF is able to protect
microtubules from alkaloid-
induced destruction. Nontrans-
fected cells did not contain intact
microtubules as detected by the
absence of tubulin staining. (D)
Summary of the domains of
MURF required for microtubule
stabilization. Microtubule inter-
action and filament formation
are required for microtubule
stabilization. Deletion of the
RING-finger domain (mutant
N81), abrogating filament for-
mation, or deletion of the leu-
cine-rich coiled-coil domain
(mutant C154), preventing mi-
crotubule association, ablates
the microtubule stabilization
function of MURF. 
Spencer et al. 
 
MURF, A Muscle-specific RING-Finger Protein
 
781
 
MURF Association with Microtubules Leads to the 
Formation of Glutamic Acid-modified Tubulin
 
Microtubules exist in several modified forms. The majority
of the tubulin contained within microtubules is tyrosinated
at its COOH terminus. Tubulin that has been detyro-
sinated can possess a glutamic acid residue at its COOH
terminus (Glu-tubulin) or this residue can be removed
(delta
 
2
 
-tubulin). Microtubules composed of modified tu-
bulin, such as Glu-tubulin and delta
 
2
 
-tubulin, have been
demonstrated to be more stable than unmodified or tyrosi-
nated tubulin (Schulze et al., 1987; Webster et al., 1987;
Webster, 1997). The more stable the microtubule, the
longer it exists without depolymerization, and the greater
the accumulation of modified tubulin within the microtu-
bule. Therefore, the degree of modification is indicative
of the age of the microtubule. As another measure of
MURF’s ability to stabilize microtubules, cells were trans-
fected with MURF or various deletion mutants of MURF
and immunostained with antibodies specific to the glutamic
acid-modified form of tubulin (Glu-tubulin). As seen in
Fig. 9 C, only cells possessing the tubular network of
MURF-bound microtubules contain Glu-tubulin, suggest-
ing these microtubules are indeed stable and have existed
for a significant period without depolymerization. Deletion
of the RING-finger domain did not lead to Glu-tubulin ac-
cumulation (Fig. 9 D, and not shown.) Microtubule binding
is required for Glu-tubulin accumulation as deletion C154
did not increase Glu-tubulin formation (Fig. 9 D, and not
shown). These data are consistent with the results of Fig. 8
demonstrating that MURF is able to stabilize microtubules
and continuous binding along microtubules is required for
this process to occur. Identical results were obtained using
a delta
 
2
 
-tubulin antibody (not shown).
To determine if MURF expression parallels the forma-
tion of Glu-modified microtubules during skeletal muscle
differentiation, C2 cells were isolated at various stages of
Figure 9. Stabilization of microtubules by MURF in vivo. (A–C) MURF expression enhances Glu-tubulin formation. Cos cells were
transfected with a MURF expression plasmid and immunostained for MURF and Glu-tubulin to detect stable microtubules 24 h after
transfection. A is MURF localization. B is the accumulation of Glu-tubulin. C is an overlay of A and B. (D) Summary of the domains of
MURF required for stabilization of microtubules as detected by the accumulation of Glu-tubulin. The RING-finger and leucine-rich
coiled-coil are required to observe Glu-tubulin accumulation. (E) MURF expression parallels the appearance of Glu-tubulin during
skeletal muscle formation in vitro. C2 cells were grown in growth medium (GM), induced to differentiate for 1, 3, or 5 d and Western
blot analysis performed to detect MURF expression and Glu-tubulin. MURF expression and Glu-tubulin accumulation occur in con-
cert. Blotting with an anti-tubulin antibody confirmed equal quantities of protein in each lane. (F) Ablation of MURF expression in
myogenin overexpressing C2 cells results in decreased Glu-tubulin accumulation. MURF expression was inhibited in myogenin overex-
pressing C2 cells by anti-MURF as described in Materials and Methods. Extracts were isolated from mock-infected and anti-MURF–
infected cells at 0 (GM) and 3 d of differentiation and Glu-tubulin levels were detected by Western blot. Total tubulin levels were used
as a loading control. Glu-tubulin levels were normalized to total tubulin by densitometry. 
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differentiation and Glu-tubulin was analyzed by Western
blot analysis. As seen in Fig. 9 E, the appearance of Glu-
tubulin mirrors the expression of MURF during muscle
differentiation. These data raise the possibility that MURF/
microtubule interaction may participate in the mechanism
regulating microtubule equilibrium during the formation
of striated muscle.
Given the parallel expression of MURF with the ap-
pearance of Glu-tubulin in skeletal muscle differentiation
and the formation of stable microtubules in MURF-expres-
sing cells, we investigated if the ablation of MURF expres-
sion affected the formation of stable microtubules during
myogenic differentiation in myogenin overexpressing mus-
cle cells. Western blot analysis was performed to detect
the accumulation of Glu-tubulin as a marker of microtu-
bule stability at 0 and 3 d of differentiation. As seen in Fig.
9 E, in mock-infected cells Glu-tubulin accumulation is
robust after three days of differentiation. In contrast, in
anti-MURF–infected cells capable of expressing myogenic
markers but unable to form myotubes, Glu-tubulin forma-
tion was significantly reduced. Normalization of the levels
of Glu-tubulin to total tubulin concentration revealed an
 
z
 
4–5-fold decrease. These data demonstrate that MURF
expression during differentiation is an integral component
in the establishment of stable microtubules required for
myotube formation.
 
Discussion
 
The results of this study identify MURF as a novel muscle-
specific RING-finger protein that stabilizes microtubules
and is essential for the initiation of myogenesis and myo-
tube formation. The selective expression of MURF in dif-
ferentiated striated muscle suggests its involvement in es-
tablishment of the stable microtubular network known
from previous studies to influence myofibrillar assembly,
contractility, and morphology of muscle cells (Antin et al.,
1981; Toyama et al., 1982).
 
MURF and Midline Proteins
 
MURF contains several distinct domains that contribute
to the stabilization of microtubules (Fig. 10). Microtubule
binding and homo-oligomerization are mediated by over-
lapping functional domains. The leucine-rich coiled-coil is
necessary and sufficient for microtubule interaction. How-
ever, amino acids 168–211 are required for optimal associ-
ation. Homo-oligomerization also is mediated by the leu-
cine-rich coiled-coil and amino acids 168–211. In contrast
to microtubule binding, the leucine-rich coiled-coil is not
sufficient for homo-oligomerization in vitro. Continuous
binding along microtubules in vivo requires the RING-fin-
ger domain of MURF.
Although MURF and Midline RING-finger proteins
share homology and the ability to associate with microtu-
bules, their overall structures are distinct, suggesting that
their functions are not identical. MURF contains one
B-box, whereas Midline proteins contain two, and Midline
proteins contain a COOH-terminal Ret-finger protein (RFP)
or butyrophilin-like domain not contained in MURF. The
expression patterns of MURF and Midline proteins are
also different. Whereas MURF expression is restricted to
striated muscle pre- and postnatally, Mid1 and Mid2 are
more ubiquitous (Quaderi et al., 1997; Buchner et al.,
1999). Embryonically, Mid1 is expressed in all developing
tissues except the heart and Mid2 is highly expressed in
the heart as well as elsewhere in the embryo.
 
Microtubules, MAPs, and Disease
 
The equilibrium of microtubules between polymerized
and depolymerized states influences a variety of cellular
processes, including morphological changes, migration,
and proliferation. The microtubule-binding properties of
MURF are similar in many respects to those of other mi-
crotubule-associated proteins, such as MAPs, Midline
family members, Doublecortin, Lis1, and Tau, which bind
and stabilize microtubules (Kosik, 1990; Takemura et al.,
1992; Kaech et al., 1996; Sapir et al., 1997, 1999; Nguyen et
al., 1997, 1998; Buchner et al., 1999; Cainarca et al., 1999;
Gleeson et al., 1999; Hsieh et al., 1999; Koulakoff et al.,
1999; Schweiger et al., 1999). However, MURF lacks the
type of microtubule association domain commonly con-
tained in MAPs but, instead, associates with microtubules
through its leucine-rich coiled-coil domain. Other microtu-
bule-binding proteins that lack the classic microtubule as-
sociation domain found in MAPs have also been identi-
fied, including Mid1, Mid2, Doublecortin and Lis1. With
the exception of Mid1 and Mid2, most nonclassical MAPs
do not share significant homology with MURF, suggesting
multiple mechanisms for microtubule interaction that may
regulate microtubule dynamics in different tissues.
Several human diseases have been linked to mutations
in genes encoding microtubule-binding proteins, demon-
strating the importance of the microtubule network for
normal patterning and development. For example, Mid1,
Doublecortin, Lis1, and Tau, all microtubule-associated
factors capable of stabilizing microtubules, have been im-
plicated in the progression of disease (Kosik, 1990; Lo Ni-
gro et al., 1997; Quaderi et al., 1997; Gleeson et al., 1999;
Koulakoff et al., 1999; Tolnay and Probst, 1999). Mutant
mice lacking the microtubule-binding proteins Kif3A and
Kif3B of the kinesin superfamily, have also been shown to
display situs inversus of the heart and other organs
(Marszalek et al., 1999; Takeda et al., 1999). A similar phe-
notype is observed in mice harboring a deleted ATP bind-
ing domain of left-right dynein (Supp et al., 1999). The
possibility that cardiomyopathies or muscular dystrophies
may be linked to MURF expression remains an interesting
prospect for the future.
Figure 10. Functional domain structure of MURF. MURF is
composed of distinct functional domains. The leucine-rich coiled-
coil domain mediates microtubule association. Amino acids 168–
211 cooperate with the leucine-rich coiled-coil domain in mediat-
ing homo-oligomerization. The RING-finger domain is required
for continuous binding along and stabilization of microtubules. 
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The Cytoskeleton in Muscle
 
Microtubules have been shown to play important roles in
regulating muscle cell morphology, sarcomere assembly,
and function. In skeletal muscle cells, the microtubule net-
work is reorganized to form stable microtubules during
differentiation (Gunderson et al., 1989). Consistent with
this requirement for stable microtubules, ablation of
MURF expression disrupts skeletal muscle differentiation
in vitro with a significant decrease in Glu-tubulin forma-
tion. Integrity of the microtubular array is essential for
proper alignment of myoblasts during fusion and for cor-
rect formation of myofibrils (Antin et al., 1981; Toyama et
al., 1982). However, given that MURF is expressed in car-
diac muscle cells that do not undergo fusion events, the
role of MURF likely extends beyond fusion alone.
By what mechanism might MURF affect myogenesis? It
is well established that myoblast fusion requires precise
cell-cell interactions, which are influenced by cell mor-
phology. Thus, perturbation of MURF expression might
distort myoblast morphology with consequent disruption
of appropriate intercellular contacts. Alternatively, or in
addition, aberrant cell shape or cytoskeletal architecture
might perturb intracellular signaling systems that ulti-
mately regulate muscle gene transcription. In this regard,
activation of gene expression by SRF, a regulator of myo-
genesis, is linked to changes in actin dynamics and cyto-
skeletal reorganization (Sotiropoulos et al., 1999). In addi-
tion, microtubule disruption agents affect the activity of
mitogen-activated protein (MAP) kinase family members,
including p38 kinase, a known regulator of myocyte en-
hancer factor 2 (MEF2) transcriptional activity and myo-
genesis (Zetser et al., 1999; Stone and Chambers, 2000).
Consistent with the conclusion that MURF is an integral
component of the mechanism that regulates microtubule
stability in muscle cells, both skeletal and cardiac muscle
have been demonstrated to possess a population of micro-
tubules that is stable to depolymerization and cold shock
(Webster, 1997). Moreover, expression of MURF mirrors
the accumulation of stable glutamic acid-modified tubulin
during myoblast differentiation in vitro and the ablation of
MURF results in decrease in Glu-tubulin accumulation. A
muscle-specific isoform of MAP4 is also expressed upon
differentiation in a pattern very similar to that of MURF
(Mangan and Olmsted, 1996). However, inhibition of
MAP4 expression during differentiation does not block
myotube formation but causes the accumulation of multi-
nucleated myotubes with a rounded morphology, likely
due to microtubule defects. In the MURF-ablated cells,
there still is significant Glu-tubulin accumulation, al-
though decreased. MAP4 may participate in the formation
of Glu-tubulin observed in the MURF-ablated cells. The
relationship between MAP4 and MURF is unclear.
Microtubule stabilization and increased microtubule
density have also been proposed as a mechanism for con-
tractile dysfunction in cardiac hypertrophy (Sato et al.,
1997). There is evidence that stabilization of the microtu-
bule array in hypertrophic cardiomyocytes is mediated by
a microtubule-associated protein, that is as yet unidenti-
fied (Sato et al., 1997). MAP4, which can stabilize microtu-
bules in vitro (Kaech et al., 1996; Nguyen et al., 1997;
Nguyen et al., 1998), is induced during pressure overload-
 
induced hypertrophy (Sato et al., 1997), making it a plausi-
ble candidate for such a factor. Interestingly, inhibiting ex-
pression of MAP4 in fibroblasts does not adversely affect
microtubule dynamics, suggesting a specialized role for
MAP4 in a muscle environment or functional redundancy
between members of the MAP family (Wang et al., 1996).
The striated muscle-restricted expression pattern and mi-
crotubule stabilizing effects of MURF make it an interest-
ing candidate for a factor contributing to contractile dys-
function in cardiac hypertrophy.
Microtubule depolymerization is also required for mito-
sis. Thus, the ability of MURF to prevent microtubule de-
polymerization is particularly intriguing in that striated
muscle cells are irreversibly postmitotic. In this regard,
MURF transfected cells are unable to divide (unpublished
results). Whether MURF plays a role in preventing cell cy-
cle reentry of differentiated cardiac and skeletal muscle
cells is an interesting question for the future.
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